All

Authors :: Dalyia N, Benjamin
Tracey R, O'Donovan
Kristian B, Laursen
Nina, Orfali
Mary R, Cahill
Nigel P, Mongan
Lorraine J, Gudas
Sharon L, McKenna
Source :: Frontiers in oncology. 12
Publication Year :: 2022
Abstract: Acute myeloid leukemia (AML) is an aggressive blood cancer with an overall survival of 30%. One form of AML, acute promyelocytic leukemia (APL) has become more than 90% curable with differentiation therapy, consisting of all

Tools